An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus

NCT02771093 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Trelagliptin
DRUG: Alogliptin

Sponsor

Takeda